SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-067952
Filing Date
2024-06-03
Accepted
2024-06-03 16:05:11
Documents
11
Period of Report
2024-06-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K rlay-20240603.htm   iXBRL 8-K 55821
  Complete submission text file 0000950170-24-067952.txt   165925

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rlay-20240603.xsd EX-101.SCH 23862
14 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20240603_htm.xml XML 4526
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 241013574
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)